Liberals will maintain their narrow majority on the court after Crawford’s victory in the first battleground state election of Trump’s second term.

NBC News projects victory for the GOP in the seats formerly held by Michael Waltz, who resigned to join the Trump administration, and Matt Gaetz.

The Democratic senator from New Jersey kept speaking for almost an hour after breaking Sen. Strom Thurmond's record from 1957.

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.

During Tuesday's session, the S&P 500 finished about 0.4% higher, seesawing between gains and losses throughout the chaotic trading day.

GM reported a 16.7% jump in U.S. sales compared to the first quarter of 2024, led my incremental gains in sales of new EVs and notable gains in full-size SUVs.

The S&P 500 and Nasdaq Composite closed higher on Tuesday as traders awaited Trump's tariffs. Here's what's on CNBC's radar going into Wednesday.

Hims & Hers is adding Zepbound, Mounjaro, and the generic injection liraglutide to its platform.

CNBC's Jim Cramer sees five issues with President Donald Trump's potential 20% blanket tariffs, including their effect on inflation and domestic manufacturing.

JPMorgan Chase and Citigroup are serving as lead underwriters in Circle's IPO, according to the prospectus.